---
title: BioAgilytix vs Fog City Bio
slug_a: bioagilytix
slug_b: fogcitybio
site: cro
review_signal_gate: closed
canonical_path: /compare/bioagilytix/fogcitybio
---

# BioAgilytix vs Fog City Bio

Side-by-side profile data from each company listing on this directory.

## BioAgilytix

- Profile: [/companies/bioagilytix](/companies/bioagilytix)

BioAgilytix — Bioanalytical CRO specializing in pharmacokinetics, immunogenicity, biomarkers, and CMC analytics with 30+ years of experience and 1,100+ employees conducting 5M+ tests annually.

Services: 11. Modalities: 4. Indications: 0. Locations: 8. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Analytical Method Development & Validation
- ICH Stability Studies
- Virology Services

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Vaccine

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## Fog City Bio

- Profile: [/companies/fogcitybio](/companies/fogcitybio)

Fog City Bio — Specialized CRO for custom immunoassay development using Simoa, HTRF, AlphaLISA, Luminex, MSD ECL, and other platforms. Direct scientist communication with rapid optimization workflows.

Services: 9. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Preclinical In Vitro Studies
- In Vitro Pharmacology
- Bioanalysis
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services
- Analytical Method Development & Validation
- CMC Analytical Development

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)

### Indications

- Data not yet provided.

### Phases

- Preclinical (General)

### Sourcing models

- Functional Service Provider (FSP)